Diabetes Board decisions

The Board dismissed the appeal due to the Veteran's death, and no final decision was made on any of the service connection claims.

The Board denied service connection for an upper extremity disability and a bilateral eye disability with headaches, finding no evidence of in-service injury or disease that could be related to the current conditions.

The Veteran's appeal was dismissed due to their death, and no final decision could be made on the merits of the claims.

The Board has remanded the case due to insufficient medical opinion regarding whether the Veteran's bilateral open angle glaucoma is secondary to his service-connected diabetes mellitus type II.

The Board has determined that the Veteran's service-connected disabilities render him incapable of securing or following a substantially gainful occupation, and thus grants his claim for total disability based on individual unemployability (TDIU).

The Board has remanded the case due to insufficient medical opinions regarding whether the Veteran's diabetes is caused or aggravated by his service-connected disabilities and chronic kidney disorder. The claim will be returned for further evaluation.

The Board has remanded the claims for service connection for diabetes mellitus, type II and sleep apnea due to incomplete development.

Service connection for Ischemic Heart Disease, Hypertension, and Diabetes Mellitus type II is granted due to the PACT Act presumption of herbicide exposure. Service connection for Bilateral Peripheral Neuropathy is REMANDED.

The Board denied the Veteran's claims for service connection for hypertension, type II diabetes, and left shoulder disability due to a failure to appear for VA examinations scheduled in March 2020.

The Veteran withdrew his appeal by submitting an Appeals Satisfaction Notice in March 2023, indicating he wished to withdraw all remaining issues associated with this appeal. As a result, the Board dismissed the appeal.

The Veteran's appeal is remanded for additional development regarding his diabetes mellitus, type II and peripheral neuropathy claims.

The Board denied the Veteran's claim for special monthly compensation based on aid and attendance due to insufficient evidence showing that he requires regular aid and assistance from another person.

The Board has denied service connection for rashes and remanded the issues of service connection for rheumatoid arthritis, gout, acquired psychiatric disorder to include PTSD and mood disorder, duodenal ulcer, gastrointestinal disorder, heart disease, diabetes mellitus, type 2 (DMII), and obstructive sleep apnea (OSA).

The Board has denied the Veteran's claims for service connection for hepatitis C, diabetes mellitus, type II, and non-Hodgkin's lymphoma. The case is being remanded due to inadequate medical opinions and lack of substantial compliance with previous remand directives.

The Board has remanded the cases due to uncertainty regarding the Veteran's diagnoses and exposure history, particularly concerning diabetes mellitus type II, polycythemia vera, and sarcoidosis. The Veteran is presumed exposed to Agent Orange during service.

The Veteran's hypertension is granted effective August 10, 2022, pursuant to The PACT Act of 2022. Other issues remain unresolved and are remanded.

The Board has determined that the Veteran does not have a current diagnosis of diabetes mellitus type II, and therefore denied his claim for service connection.

The Board has remanded the cases for further development and to obtain additional medical opinions regarding service connection.

The Veteran's claims for service connection for Parkinson's disease and diabetes mellitus type II are granted based on the PACT Act presumption of exposure to herbicides in Guam. The claims for left and right lower extremity peripheral neuropathy are remanded due to potential Vietnam service.

The Board has decided to remand the cases for further evaluation due to new VA treatment records submitted after the most recent Statement of the Case.